In those studies, AID levels were found to be associated with IgV-UM CLL, with chromosomal aberrations and a shorter overall survival as well as shorter time to first treatment [9],[10],[12]. This evidence concerns the gene AICDA and B-cell chronic lymphocytic leukemia.